Stock Detail
$OSCR
Healthcare · 24 tracked mentions in the last 90 days across 7 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
OSCR leans undervalued across 3 creators and 3 classified valuation claims, with 2 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: price target upside
we're going to see a rebound to 30, maybe even 35 and I think on the very very high side of things, I think we could see Oscar go to $40 per share
Explicit claim • strong conviction • basis: multiple relative
Moving on to Oscar Healthier, another one of those names where I do think it's still cheap. If they do achieve their own guidance for 2026, which in the interview I had with CEO, seems like they're going to meet it. Stock is cheap. You'll see a re-rating.
Explicit claim • strong conviction • basis: fair value gap
DCF model values the stock at $29.83 per share.
Implied claim • strong conviction • basis: market mispricing
I would consider it for Oscar. The downside potential is insane. Bas and it's not just like, oh, it just ran up, you know, randomly and it's never crashed. No, it's done this multiple different times. We're approaching a previous resistance, which again, patterns tend to repeat themselves.
Mention History
Latest mentions across all history
Feed